Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiaromatase agents: evolving role in adjuvant therapy.

Stephen E Jones1

  • 1Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, TX 75246, USA. steve.jones@usoncology.com

Clinical Breast Cancer
|May 22, 2002
PubMed
Summary

Adjuvant hormonal therapy aims to prevent breast cancer recurrence. Aromatase inhibitors show promise as alternatives to tamoxifen, with ongoing trials evaluating their efficacy and tolerability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiofrequency-induced heating safety of brain MRI scans at 7 T in the presence of a shoulder implant.

Magnetic resonance imaging·2026
Same author

Agreement and Comparative Performance of Cognitive Testing, Visual MRI Rating, and Automated Brain Morphometry in Older Adults with Suspected Dementia in Uganda.

Degenerative neurological and neuromuscular disease·2026
Same author

Neuroanatomical correlates of neuropsychological dysfunction in pediatric pharmacoresistant epilepsy due to focal cortical dysplasia type II.

Epilepsia open·2026
Same author

Clinical use and radiological yield of magnetic resonance fingerprinting in epilepsy.

Epilepsia·2026
Same author

A rapid educational intervention to enhance brain MRI interpretation skills of radiology professionals for dementia diagnosis in Uganda: a pre- and post-intervention study.

BMC medical education·2026
Same author

Efficient Whole-Brain Quantitative Magnetization Transfer Imaging at 3T Using Segmented EPI Readout with Variable Power Magnetization Transfer Pulses (EP-vpMT).

NeuroImage·2025

Area of Science:

  • Oncology
  • Endocrinology

Background:

  • Adjuvant hormonal therapy is crucial for preventing breast cancer recurrence.
  • Tamoxifen is a standard treatment, but tolerability issues limit its use in some patients.

Purpose of the Study:

  • To review the role of aromatase inhibitors in adjuvant breast cancer therapy.
  • To compare the efficacy and tolerability of aromatase inhibitors versus tamoxifen.
  • To discuss ongoing trials investigating optimal sequencing and combination therapy.

Main Methods:

  • Review of existing clinical trial data comparing aromatase inhibitors (exemestane, letrozole, anastrozole) with tamoxifen.
  • Analysis of efficacy endpoints (e.g., recurrence rates) and tolerability profiles.
  • Discussion of current research in adjuvant settings.

Main Results:

  • Aromatase inhibitors have demonstrated equivalent or superior efficacy to tamoxifen in metastatic breast cancer.
  • These agents often present improved tolerability compared to tamoxifen.
  • Ongoing adjuvant trials are essential to confirm these findings in the adjuvant setting.

Conclusions:

  • Aromatase inhibitors represent a promising alternative or addition to tamoxifen in adjuvant breast cancer treatment.
  • Further research is needed to optimize treatment strategies, including therapy sequencing and combination approaches.
  • Improved tolerability and efficacy of aromatase inhibitors may enhance patient outcomes in breast cancer management.

Related Experiment Videos